Recommendations on hematopoietic stem cell transplantation for patients with Diamond–Blackfan anemia. On behalf of the Pediatric Diseases and Severe Aplastic Anemia Working Parties of the EBMT

Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Selim Corbacioglu(Unknown), Lawrence Faulkner(Faulkner University), Brigitte Strahm(University Medical Center Freiburg), Dorine Bresters(Willem-Alexander Kinderziekenhuis), Régis Peffault de Latour(Hôpital Saint-Louis), Maurizio Miano(Istituto Giannina Gaslini), Akif Yeşilipek(Bahçeşehir University), Jean‐Hugues Dalle(Inserm)
Bone Marrow Transplantation
August 31, 2021
10.1038/s41409-021-01449-w
Cited by 29

Related Papers

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
|New England Journal of Medicine|2020|1.8k
B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
|Nature Immunology|2011|724
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2016|538
Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel
|Haematologica|2014|389
Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT)
|Bone Marrow Transplantation|2015|387